Personal profile
Headline
ASSOCIATE PROFESSOR, Medicine, Hematology and Medical Oncology, The Tisch Cancer Institute
Biography
Dr. Iancu-Rubin completed her Bachelor and Master Degrees at the University of Bucharest in Romania in 1989 and 1992, respectively. She pursued a career in clinical laboratory medicine and teaching until 1997 when she was awarded a Fulbright Fellowship in biomedical sciences. As Fulbright Scholar she completed her graduate studies at the Graduate School of Biomedical Sciences at Mount Sinai Medical Center in New York. Dr. Iancu-Rubin received her Ph.D. in Life Sciences in 2000 and did her post-doctoral training in hematology. Currently, she is faculty member of the NCI-designated Tisch Cancer Institute and of the Department of Medicine at Icahn School of Medicine at Mount Sinai and the Director of Hematological Malignancies Tissue Bank. Dr. Iancu-Rubin has been investigator on NIH-funded, foundation and institutional projects as well as on industry-sponsored preclinical and clinical studies. She is conducting research independently and within the MPN and NYSTEM Research Consortiums. Her research focuses on normal and malignant hematopoiesis and megakaryopoiesis with emphasis on pre-clinical and clinical evaluation of drug-based and cellular therapies for patients with hematological malignancies. Dr. Iancu-Rubin’s research has been recognized in highly ranked peer-reviewed publications and her expertise has been sought by multiple collaborators.
Fingerprint
Dive into the research topics where Camelia Iancu-Rubin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Hematopoietic Progenitor Cell Products Derived From Bone Marrow and Peripheral Blood
Iancu-Rubin, C. & Weinberg, R. S., 1 Jan 2024, Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. Elsevier, p. 423-426 4 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Overview of Cellular Therapy
Iancu-Rubin, C. & Weinberg, R. S., 1 Jan 2024, Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. Elsevier, p. 417-422 6 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
1 Scopus citations -
Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes
Keyzner, A., Azzi, J., Jakubowski, R., Sinitsyn, Y., Tindle, S., Shpontak, S., Kwon, D., Isola, L. & Iancu-Rubin, C., Oct 2023, In: Transplantation Proceedings. 55, 8, p. 1799-1809 11 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
Wang, X., Rampal, R. K., Hu, C. S., Tripodi, J., Farnoud, N., Petersen, B., Rossi, M. R., Patel, M., McGovern, E., Najfeld, V., Iancu-Rubin, C., Lu, M., Davis, A., Kremyanskaya, M., Weinberg, R. S., Mascarenhas, J. & Hoffman, R., 22 Apr 2022, In: JCI insight. 7, 8, e156534.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Essential Thrombocythemia
Marcellino, B. K., Mascarenhas, J., Iancu-Rubin, C., Kremyanskaya, M., Najfeld, V. & Hoffman, R., 1 Jan 2022, Hematology: Basic Principles and Practice, Eighth Edition. Elsevier, p. 1169-1192 24 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
1 Scopus citations
Press/Media
-
New Findings from Icahn School of Medicine at Mount Sinai in the Area of COVID-19 Reported (Cryopreservation of Allogeneic Hematopoietic Cell Products During Covid-19 Pandemic: Graft Characterization and Engraftment Outcomes)
Isola, L., Keyzner, A. & Iancu-Rubin, C.
5/12/23
1 item of Media coverage
Press/Media
-
-
Production of Megakaryoctye Compositions and Therapies for Treatment of Thrombocytopenia
1/08/23
1 item of Media coverage
Press/Media
-
Australia Patent: Application for 'Production of megakaryoctye compositions and therapies for treatment of thrombocytopenia' Lapses
6/08/21
1 item of Media coverage
Press/Media